831 related articles for article (PubMed ID: 12945718)
41. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
Gatto M; Saccon F; Zen M; Regola F; Fredi M; Andreoli L; Tincani A; Urban ML; Emmi G; Ceccarelli F; Conti F; Bortoluzzi A; Govoni M; Tani C; Mosca M; Ubiali T; Gerosa M; Bozzolo E; Canti V; Cardinaletti P; Gabrielli A; Tanti G; Gremese E; De Marchi G; De Vita S; Fasano S; Ciccia F; Pazzola G; Salvarani C; Negrini S; Puppo F; Di Matteo A; De Angelis R; Orsolini G; Rossini M; Faggioli P; Laria A; Piga M; Mathieu A; Scarpato S; Rossi FW; de Paulis A; Brunetta E; Ceribelli A; Selmi C; Prete M; Racanelli V; Vacca A; Bartoloni E; Gerli R; Larosa M; Iaccarino L; Doria A
Arthritis Rheumatol; 2020 Aug; 72(8):1314-1324. PubMed ID: 32275125
[TBL] [Abstract][Full Text] [Related]
42. Juvenile systemic lupus erythematosus: onset patterns and short-term outcome in Egyptian children, a single-center experience.
Abdel-Hafez MA; Abdel-Nabi H
Lupus; 2015 Nov; 24(13):1455-61. PubMed ID: 26223297
[TBL] [Abstract][Full Text] [Related]
43. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
[TBL] [Abstract][Full Text] [Related]
44. Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation.
Swaak AJ; van den Brink HG; Smeenk RJ; Manger K; Kalden JR; Tosi S; Marchesoni A; Domljan Z; Rozman B; Logar D; Pokorny G; Kovacs L; Kovacs A; Vlachoyiannopoulos PG; Moutsopoulos HM; Chwalinska-Sadowska H; Dratwianka B; Kiss E; Cikes N; Branimir A; Schneider M; Fischer R; Bombardieri S; Mosca M; Smolen JS
Rheumatology (Oxford); 1999 Oct; 38(10):953-8. PubMed ID: 10534545
[TBL] [Abstract][Full Text] [Related]
45. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
Appenzeller S; Pereira DA; Costallat LT
Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
[TBL] [Abstract][Full Text] [Related]
46. Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
Joo YB; Park SY; Won S; Bae SC
J Rheumatol; 2016 Aug; 43(8):1490-7. PubMed ID: 27252431
[TBL] [Abstract][Full Text] [Related]
47. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Rheumatology (Oxford); 2007 Aug; 46(8):1290-6. PubMed ID: 17522097
[TBL] [Abstract][Full Text] [Related]
48. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
[TBL] [Abstract][Full Text] [Related]
49. Abnormality in hippocampal signal intensity predicts atrophy in patients with systemic lupus erythematosus.
Lapa AT; Pedro T; Francischinelli J; Coan AC; Costallat LT; Cendes F; Appenzeller S
Lupus; 2017 May; 26(6):633-639. PubMed ID: 27879427
[TBL] [Abstract][Full Text] [Related]
50. Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus.
Brunner HI; Bishnoi A; Barron AC; Houk LJ; Ware A; Farhey Y; Mongey AB; Strife CF; Graham TB; Passo MH
Lupus; 2006; 15(4):198-206. PubMed ID: 16686258
[TBL] [Abstract][Full Text] [Related]
51. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
[TBL] [Abstract][Full Text] [Related]
52. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
[TBL] [Abstract][Full Text] [Related]
53. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
Zen M; Bassi N; Nalotto L; Canova M; Bettio S; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
Clin Exp Rheumatol; 2012; 30(6):856-63. PubMed ID: 22765883
[TBL] [Abstract][Full Text] [Related]
54. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
55. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
56. The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis.
Rizk A; Gheita TA; Nassef S; Abdallah A
Int J Rheum Dis; 2012 Jun; 15(3):261-7. PubMed ID: 22212605
[TBL] [Abstract][Full Text] [Related]
57. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
Ibañez D; Gladman D; Urowitz M
J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
[TBL] [Abstract][Full Text] [Related]
58. Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus.
Ma H; Dong J; Wang L; Zhao L; Pan L
Clin Rheumatol; 2018 Jan; 37(1):101-105. PubMed ID: 28776301
[TBL] [Abstract][Full Text] [Related]
59. [Determinant Factors of Morbidity in Patients with Systemic Lupus Erythematosus].
Jacinto M; Silva E; Riso N; Moraes-Fontes MF
Acta Med Port; 2017 May; 30(5):368-372. PubMed ID: 28865500
[TBL] [Abstract][Full Text] [Related]
60. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
Pusongchai T; Jungthirapanich J; Khositseth S
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
